228 related articles for article (PubMed ID: 25999406)
1. Nuclear Factor Erythroid 2-Related Factor 2 Drives Podocyte-Specific Expression of Peroxisome Proliferator-Activated Receptor γ Essential for Resistance to Crescentic GN.
Henique C; Bollee G; Lenoir O; Dhaun N; Camus M; Chipont A; Flosseau K; Mandet C; Yamamoto M; Karras A; Thervet E; Bruneval P; Nochy D; Mesnard L; Tharaux PL
J Am Soc Nephrol; 2016 Jan; 27(1):172-88. PubMed ID: 25999406
[TBL] [Abstract][Full Text] [Related]
2. Zhen-wu-tang protects against podocyte injury in rats with IgA nephropathy via PPARγ/NF-κB pathway.
Liu B; He Y; Lu R; Zhou J; Bai L; Zhang P; Ye S; Wu J; Liang C; Zhou Y; Zhou J
Biomed Pharmacother; 2018 May; 101():635-647. PubMed ID: 29518610
[TBL] [Abstract][Full Text] [Related]
3. Podocytes are new cellular targets of haemoglobin-mediated renal damage.
Rubio-Navarro A; Sanchez-Niño MD; Guerrero-Hue M; García-Caballero C; Gutiérrez E; Yuste C; Sevillano Á; Praga M; Egea J; Román E; Cannata P; Ortega R; Cortegano I; de Andrés B; Gaspar ML; Cadenas S; Ortiz A; Egido J; Moreno JA
J Pathol; 2018 Mar; 244(3):296-310. PubMed ID: 29205354
[TBL] [Abstract][Full Text] [Related]
4. The protective role of peroxisome proliferator-activated receptor gamma in lipotoxic podocytes.
Carrasco AG; Izquierdo-Lahuerta A; Valverde ÁM; Ni L; Flores-Salguero E; Coward RJ; Medina-Gómez G
Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Jul; 1868(7):159329. PubMed ID: 37156296
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis.
Yang HC; Ma LJ; Ma J; Fogo AB
Kidney Int; 2006 May; 69(10):1756-64. PubMed ID: 16598202
[TBL] [Abstract][Full Text] [Related]
6. Effects of different PPARgamma-agonists on MCP-1 expression and monocyte recruitment in experimental glomerulonephritis.
Panzer U; Schneider A; Guan Y; Reinking R; Zahner G; Harendza S; Wolf G; Thaiss F; Stahl RA
Kidney Int; 2002 Aug; 62(2):455-64. PubMed ID: 12110006
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis.
Bollée G; Flamant M; Schordan S; Fligny C; Rumpel E; Milon M; Schordan E; Sabaa N; Vandermeersch S; Galaup A; Rodenas A; Casal I; Sunnarborg SW; Salant DJ; Kopp JB; Threadgill DW; Quaggin SE; Dussaule JC; Germain S; Mesnard L; Endlich K; Boucheix C; Belenfant X; Callard P; Endlich N; Tharaux PL
Nat Med; 2011 Sep; 17(10):1242-50. PubMed ID: 21946538
[TBL] [Abstract][Full Text] [Related]
8. Nrf2-regulated PPAR{gamma} expression is critical to protection against acute lung injury in mice.
Cho HY; Gladwell W; Wang X; Chorley B; Bell D; Reddy SP; Kleeberger SR
Am J Respir Crit Care Med; 2010 Jul; 182(2):170-82. PubMed ID: 20224069
[TBL] [Abstract][Full Text] [Related]
9. Genetic and Pharmacologic Targeting of Glycogen Synthase Kinase 3β Reinforces the Nrf2 Antioxidant Defense against Podocytopathy.
Zhou S; Wang P; Qiao Y; Ge Y; Wang Y; Quan S; Yao R; Zhuang S; Wang LJ; Du Y; Liu Z; Gong R
J Am Soc Nephrol; 2016 Aug; 27(8):2289-308. PubMed ID: 26647425
[TBL] [Abstract][Full Text] [Related]
10. Loss of the tumor suppressor Vhlh leads to upregulation of Cxcr4 and rapidly progressive glomerulonephritis in mice.
Ding M; Cui S; Li C; Jothy S; Haase V; Steer BM; Marsden PA; Pippin J; Shankland S; Rastaldi MP; Cohen CD; Kretzler M; Quaggin SE
Nat Med; 2006 Sep; 12(9):1081-7. PubMed ID: 16906157
[TBL] [Abstract][Full Text] [Related]
11. Genetic and pharmacological inhibition of microRNA-92a maintains podocyte cell cycle quiescence and limits crescentic glomerulonephritis.
Henique C; Bollée G; Loyer X; Grahammer F; Dhaun N; Camus M; Vernerey J; Guyonnet L; Gaillard F; Lazareth H; Meyer C; Bensaada I; Legrès L; Satoh T; Akira S; Bruneval P; Dimmeler S; Tedgui A; Karras A; Thervet E; Nochy D; Huber TB; Mesnard L; Lenoir O; Tharaux PL
Nat Commun; 2017 Nov; 8(1):1829. PubMed ID: 29184126
[TBL] [Abstract][Full Text] [Related]
12. Alternatively Spliced Landscape of PPARγ mRNA in Podocytes Is Distinct from Adipose Tissue.
Bryant C; Webb A; Banks AS; Chandler D; Govindarajan R; Agrawal S
Cells; 2022 Nov; 11(21):. PubMed ID: 36359851
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial dysfunction mediates aldosterone-induced podocyte damage: a therapeutic target of PPARγ.
Zhu C; Huang S; Yuan Y; Ding G; Chen R; Liu B; Yang T; Zhang A
Am J Pathol; 2011 May; 178(5):2020-31. PubMed ID: 21514419
[TBL] [Abstract][Full Text] [Related]
14. Reduction in podocyte SIRT1 accelerates kidney injury in aging mice.
Chuang PY; Cai W; Li X; Fang L; Xu J; Yacoub R; He JC; Lee K
Am J Physiol Renal Physiol; 2017 Sep; 313(3):F621-F628. PubMed ID: 28615249
[TBL] [Abstract][Full Text] [Related]
15. Sildenafil Prevents Podocyte Injury
Sonneveld R; Hoenderop JG; Isidori AM; Henique C; Dijkman HB; Berden JH; Tharaux PL; van der Vlag J; Nijenhuis T
J Am Soc Nephrol; 2017 May; 28(5):1491-1505. PubMed ID: 27895156
[TBL] [Abstract][Full Text] [Related]
16. Amelioration of crescentic glomerulonephritis by RhoA kinase inhibitor, Fasudil, through podocyte protection and prevention of leukocyte migration.
Hidaka T; Suzuki Y; Yamashita M; Shibata T; Tanaka Y; Horikoshi S; Tomino Y
Am J Pathol; 2008 Mar; 172(3):603-14. PubMed ID: 18245810
[TBL] [Abstract][Full Text] [Related]
17. Activation of Notch3 in Glomeruli Promotes the Development of Rapidly Progressive Renal Disease.
El Machhour F; Keuylian Z; Kavvadas P; Dussaule JC; Chatziantoniou C
J Am Soc Nephrol; 2015 Jul; 26(7):1561-75. PubMed ID: 25421557
[TBL] [Abstract][Full Text] [Related]
18. Activation of peroxisome proliferator-activated receptor-γ coactivator 1α ameliorates mitochondrial dysfunction and protects podocytes from aldosterone-induced injury.
Yuan Y; Huang S; Wang W; Wang Y; Zhang P; Zhu C; Ding G; Liu B; Yang T; Zhang A
Kidney Int; 2012 Oct; 82(7):771-89. PubMed ID: 22648295
[TBL] [Abstract][Full Text] [Related]
19. Podocyte involvement in human immune crescentic glomerulonephritis.
Bariéty J; Bruneval P; Meyrier A; Mandet C; Hill G; Jacquot C
Kidney Int; 2005 Sep; 68(3):1109-19. PubMed ID: 16105041
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor: a new therapeutic target in glomerular disease.
Flamant M; Bollée G; Hénique C; Tharaux PL
Nephrol Dial Transplant; 2012 Apr; 27(4):1297-304. PubMed ID: 22467748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
